Race to stop diabetes before it starts: two drugs Head-to-Head
NCT ID NCT07216391
Summary
This study aims to see if two different drugs can delay or prevent the onset of insulin-dependent Type 1 diabetes in people who are at high risk. It will enroll 60 participants, aged 4 to 35, who have early signs of the disease but do not yet need insulin. Participants will receive one of the two drugs via infusions and be monitored for one year to see which treatment is more effective at stopping the disease from progressing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Florida
Gainesville, Florida, 32610, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.